Clinical trial
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical…
NCT00206388 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00206388 |
|---|---|
| Title | Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement |
| Official title | A Phase I Study of Zoledronic Acid (Zometa) With Cyclophosphamide in Children With Recurrent or Refractory Neuroblastoma and Cortical Bone Involvement (NANT 2004-01) |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | New Approaches to Neuroblastoma Therapy Consortium |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | NEUROBLASTOMA |
| Intervention type | Drug |
| Interventions | Zolendric acid, Cyclophosphamide |
| Enrollment | 21 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | May 1, 2013 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: